HENDERSON MICHAEL THOMAS
CIK 1779990
Transactions on file
36
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-03 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Disp. | 920,941 | $0.00 | — | open → |
| 2026-07-11 | 2026-07-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Gift | 75,046 | $0.00 | — | open → |
| 2026-07-11 | 2026-07-08 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 20,000 | $2.67M | +1.1% | open → |
| 2026-06-25 | 2026-06-22 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 80,000 | $10.60M | +1.9% | open → |
| 2026-06-24 | 2026-06-22 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 20,000 | $2.00M | -11.0% | open → |
| 2026-06-12 | 2026-06-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 614 | $53.4K | +55.4% | open → |
| 2026-06-12 | 2026-06-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 2,305 | $198.9K | +56.6% | open → |
| 2026-06-12 | 2026-06-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,577 | $134.3K | +58.6% | open → |
| 2026-06-12 | 2026-06-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,080 | $90.9K | +60.5% | open → |
| 2026-06-12 | 2026-06-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 7,654 | $633.6K | +63.2% | open → |
| 2026-06-12 | 2026-06-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 6,770 | $556.6K | +64.3% | open → |
| 2026-05-16 | 2026-05-13 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,341 | $110.7K | +63.6% | open → |
| 2026-05-16 | 2026-05-13 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 18,659 | $1.53M | +64.6% | open → |
| 2026-04-20 | 2026-04-16 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Exer. | 3,000 | $68.6K | +490.9% | open → |
| 2026-04-10 | 2026-04-08 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 200 | $17.0K | +58.9% | open → |
| 2026-04-10 | 2026-04-08 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 2,000 | $166.5K | +62.2% | open → |
| 2026-04-10 | 2026-04-08 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 17,800 | $1.47M | +63.8% | open → |
| 2025-01-10 | 2025-01-08 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 2,868 | $141.6K | +173.5% | open → |
| 2025-01-10 | 2025-01-08 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 12,132 | $591.1K | +177.2% | open → |
| 2025-01-14 | 2025-01-10 | SYRE Spyre Therapeutics, Inc. | Director | Other | 105,379 | $0.00 | — | open → |
| 2025-01-31 | 2025-01-31 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Exer. | 8,500 | $194.3K | +490.9% | open → |
| 2025-02-07 | 2025-02-05 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 15,000 | $608.7K | +232.8% | open → |
| 2025-03-07 | 2025-03-05 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 7,326 | $219.6K | +350.5% | open → |
| 2025-03-07 | 2025-03-05 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 2,674 | $81.9K | +341.1% | open → |
| 2026-05-09 | 2026-05-08 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 19,269 | $1.45M | +18.1% | open → |
| 2026-05-09 | 2026-05-08 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 24,814 | $1.86M | +19.0% | open → |
| 2026-05-09 | 2026-05-08 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 33,513 | $2.47M | +20.7% | open → |
| 2026-05-09 | 2026-05-08 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 2,404 | $174.5K | +22.6% | open → |
| 2025-12-12 | 2025-12-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 560 | $42.9K | +76.4% | open → |
| 2025-12-12 | 2025-12-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 10,005 | $758.3K | +78.2% | open → |
| 2025-12-12 | 2025-12-10 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 9,435 | $706.5K | +80.4% | open → |
| 2025-12-05 | 2025-12-04 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 40,000 | $3.00M | +80.1% | open → |
| 2025-11-13 | 2025-11-13 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 100 | $6.5K | +109.3% | open → |
| 2025-11-13 | 2025-11-13 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,786 | $114.1K | +111.4% | open → |
| 2025-11-13 | 2025-11-13 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 14,774 | $932.8K | +113.9% | open → |
| 2025-11-13 | 2025-11-13 | APGE Apogee Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,340 | $206.8K | +118.1% | open → |
